Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TiGenix
Biotech
Takeda hands over $150M to Denali for neurodegenerative work
Takeda has struck two deals this morning as it looks to make good on its ongoing R&D reorganization.
Ben Adams
Jan 5, 2018 7:22am
Takeda strikes €520M deal to buy cell therapy firm TiGenix
Jan 5, 2018 6:14am
Chutes & Ladders—Teva taps Lundbeck chief with $52M package
Sep 15, 2017 8:27am
EuroBiotech: More Articles of Note
Sep 14, 2017 8:03am
EuroBiotech: More Articles of Note
Mar 16, 2017 9:14am
Takeda, TiGenix stem cell therapy shows sustained effect
Feb 17, 2017 4:20am
